Stefka Gyoneva is a Senior Manager and Principal Scientist at Cerevel Therapeutics, with a robust background in neurobiology and pharmacology. Prior experience includes a significant tenure at Biogen, where multiple roles were held from Postdoctoral Scientist to Scientist II, contributing to microglial function research. Previous positions include a Postdoctoral Fellowship at Lerner Research Institute, involvement in innovative imaging techniques at Emory University, and an internship at Merck focusing on hybridoma generation. Stefka graduated with a Ph.D. in Biological and Biomedical Sciences from Emory University, following a B.S. in Applied Biology from Georgia Institute of Technology. Accomplishments include protocol development for cell isolation and establishing research capabilities at Biogen.